menu
menu

World experts in freeze-drying

With the recent expansion of our pharmaceutical manufacturing unit Sofarimex, we have cutting-edge technology in the manufacture of freeze-dried products, and are among the top global manufacturers of this type of product.

Quality for all over the globe

The products manufactured by us are distributed in all continents. We bring the european quality to the most challenging markets

Focus on flexibility and agility

We work to meet the patient needs. We are focused on satisfying our costumers requests, offering a service knowed by a high level of flexibility and agility

Pharma 4.0

Our vision involves the continuous investment on people, infrastructures and pharma 4.0 solutions. The digitalization and the process automation it is our brand mark.

SOFARIMEX in figures

Over 55 direct clients

Over 280 formulations

Over 50 countries

Over 1050 products

Over 60M units and 85% of exported products

Services

Production of pharmaceuticals

Development of new products, formulations and processes

Physico-chemical and microbiological quality control/stability studies

Development and validation of analytical methods

Regulatory Support

With a portfolio of more than 1000 products, it exports to more than 50 countries in all 5 continents.

SOFARIMEX in the world

SOFARIMEX specialises in the pharmaceutical production of small and medium series

Freeze-dried injectables and sterile eye drops

Eye drops, small volume liquid injectables and freeze-dried.

Solids

Powders, granules, tablets, coated tablets, dragees and capsules.

Liquids and pastes

Syrups, solutions, suspensions and solutes. Ointments and creams.

Installed
package

180M capacity

Sofarimex Quality

Sofarimex complies with the strictest pharmaceutical standards (GMP's) and we are recognised by the most demanding agencies.

Some of our clients

Dafra
Farmaprojects
Glaxosmithkline
Med-Healtcare
Midas-Pharma
Omega-Pharma
Polpharma
Virbac
Zentiva
Azevedos

Business opportunities

Would you like to be our business partner? Please contact us.

News